{"adverse_reactions":["Adverse Reactions"],"clinical_pharmacology":["Clinical Pharmacology"],"contraindications":["Contraindications"],"description":["Description"],"dosage_and_administration":["Dosage and Administration"],"effective_time":"20190423","geriatric_use":["Elderly"],"how_supplied":["How supplied"],"id":"87388b8c-daa4-3fbb-e053-2a91aa0a3e9b","indications_and_usage":["Indications and Usage"],"openfda":{},"overdosage":["Overdosage"],"package_label_principal_display_panel":["Package Label Label","610-60","903-90"],"pharmacokinetics":["Pharmacokinetics"],"precautions":["Precautions"],"set_id":"270b68a6-1469-190d-e054-00144ff8d46c","spl_product_data_elements":["METHOCARBAMOL METHOCARBAMOL CROSCARMELLOSE SODIUM FERRIC OXIDE YELLOW FERRIC OXIDE RED HYDROXYPROPYL CELLULOSE (1600000 WAMW) HYPROMELLOSES MAGNESIUM STEARATE POLYETHYLENE GLYCOL, UNSPECIFIED TRIACETIN TITANIUM DIOXIDE METHOCARBAMOL METHOCARBAMOL CELLULOSE, MICROCRYSTALLINE AP211 Methocarbamol Methocarbamol POVIDONE POLYSORBATE 80 SODIUM LAURYL SULFATE TITANIUM DIOXIDE SILICON DIOXIDE SODIUM STARCH GLYCOLATE TYPE A POTATO STARCH, CORN STEARIC ACID FD&C YELLOW NO. 6 FOOD YELLOW 3 FREE ACID HYDROXYPROPYL CELLULOSE (1600000 WAMW) METHOCARBAMOL METHOCARBAMOL HYPROMELLOSE 2910 (6 MPA.S) PROPYLENE GLYCOL G;500 METHOCARBAMOL METHOCARBAMOL METHOCARBAMOL METHOCARBAMOL SODIUM LAURYL SULFATE SODIUM STARCH GLYCOLATE TYPE A POTATO POVIDONE K90 POLYETHYLENE GLYCOL, UNSPECIFIED MAGNESIUM STEARATE SILICON DIOXIDE HYDROXYPROPYL CELLULOSE (1600000 WAMW) STEARIC ACID White to Offwhite 115;H Capsule shaped"],"spl_unclassified_section":["SPL Unclassified"],"use_in_specific_populations":["Special Populations The clearance of methocarbamol in 8 renally-impaired patients on maintenance hemodialysis was reduced about 40% compared to 17 normal subjects, although the mean (± SD) elimination half-life in these two groups was similar: 1.2 (± 0.6) versus 1.1 (± 0.3) hours, respectively."],"version":"4","warnings":["Warnings"]}